These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 30619284)
1. TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells. Zhang B; Liu Y; Wang X; Li J; Xu X; Guo L; Ho WZ Front Immunol; 2018; 9():2921. PubMed ID: 30619284 [TBL] [Abstract][Full Text] [Related]
2. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes. Wang Y; Ye L; Wang X; Li J; Song L; Ho W Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457 [TBL] [Abstract][Full Text] [Related]
3. Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes. Wang Y; Li J; Wang X; Ye L; Zhou Y; Ho W J Viral Hepat; 2013 Jun; 20(6):385-94. PubMed ID: 23647955 [TBL] [Abstract][Full Text] [Related]
4. Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells. Zhou L; Li JL; Zhou Y; Liu JB; Zhuang K; Gao JF; Liu S; Sang M; Wu JG; Ho WZ Mol Hum Reprod; 2015 Dec; 21(12):917-29. PubMed ID: 26502803 [TBL] [Abstract][Full Text] [Related]
5. Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages. Li J; Wang Y; Wang X; Ye L; Zhou Y; Persidsky Y; Ho W Blood; 2013 Apr; 121(15):2934-42. PubMed ID: 23401273 [TBL] [Abstract][Full Text] [Related]
6. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model. Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792 [TBL] [Abstract][Full Text] [Related]
7. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon. Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097 [TBL] [Abstract][Full Text] [Related]
8. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo. Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver. Suslov A; Boldanova T; Wang X; Wieland S; Heim MH Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639 [TBL] [Abstract][Full Text] [Related]
10. Human Cervical Epithelial Cells Release Antiviral Factors and Inhibit HIV Replication in Macrophages. Xu XQ; Guo L; Wang X; Liu Y; Liu H; Zhou RH; Gu J; Liu JB; Xu P; Zhou L; Ho WZ J Innate Immun; 2019; 11(1):29-40. PubMed ID: 30032138 [TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity. Lan T; Wei Z; He Y; Wan S; Liu L; Cheng B; Li R; Chen H; Liu G; Meng Z Virol J; 2021 Feb; 18(1):37. PubMed ID: 33602251 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. Wang B; Trippler M; Pei R; Lu M; Broering R; Gerken G; Schlaak JF J Hepatol; 2009 Dec; 51(6):1037-45. PubMed ID: 19716616 [TBL] [Abstract][Full Text] [Related]
13. Hepatic stellate cells, liver innate immunity, and hepatitis C virus. Wang Y; Li J; Wang X; Sang M; Ho W J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):112-5. PubMed ID: 23855305 [TBL] [Abstract][Full Text] [Related]
14. Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages. Guo L; Xu XQ; Zhou L; Zhou RH; Wang X; Li JL; Liu JB; Liu H; Zhang B; Ho WZ Front Immunol; 2018; 9():247. PubMed ID: 29515574 [TBL] [Abstract][Full Text] [Related]
15. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways. Pei RJ; Chen XW; Lu MJ World J Gastroenterol; 2014 Sep; 20(33):11618-29. PubMed ID: 25206268 [TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes. Wang YZ; Li JL; Wang X; Zhang T; Ho WZ World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296 [TBL] [Abstract][Full Text] [Related]
18. Control of hepatitis B virus replication by innate response of HepaRG cells. Lucifora J; Durantel D; Testoni B; Hantz O; Levrero M; Zoulim F Hepatology; 2010 Jan; 51(1):63-72. PubMed ID: 19877170 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line. Wang Y; Li J; Wang X; Ye L; Zhou Y; Thomas RM; Ho W Innate Immun; 2014 Jan; 20(1):3-11. PubMed ID: 23529855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]